PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Physical Sciences, Indian Institute of Science Education and Research, Mohali, India.\', \'Graduate School of Systemic Neuroscience, Ludwig Maximilian University of Munich, Munich, Germany.\', \'Klinikum rechts der Isar, Technische Universität München, München, Germany.\', \'Department of Biological Sciences, Indian Institute of Science Education and Research, Mohali, India.\', \'Department of Chemical Sciences, Indian Institute of Science Education and Research, Mohali, India.\', \'Institute of Molecular Immunology and Experimental Oncology, Klinikum rechts der Isar, Technische Universität München, München, Germany.\', \'The Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom.\', \'Interdisciplinary Bioscience DTP, University of Oxford, Oxford, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pone.0248553
?:doi
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 33735271
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
?:title
  • A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all